ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in New Haven, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Pneumonia
Human Influenza
Virus Diseases
Respiratory Tract Infections

COVID-19 trials near New Haven, CT, USA:

SPI-1005 Treatment in Moderate COVID-19 Patients

multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and moderate symptoms of COVID...

Invitation-only
Covid19
Corona Virus Infection
Drug: Ebselen
Drug: Placebo

Phase 2

Sound Pharmaceuticals

New Haven, Connecticut, United States and 6 other locations

The proposed trial will obtain preliminary data on the feasibility of studying RTB101 as compared to placebo for COVID-19 post-expo...

Active, not recruiting
Covid19
Drug: Placebo
Drug: RTB101

Phase 2

resTORbio

Farmington, Connecticut, United States and 1 other location

vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...

Active, not recruiting
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: VXA-CoV2-3.3

Phase 2

Vaxart

Waterbury, Massachusetts, United States of America and 144 other locations

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 3

Pfizer
Pfizer

East Setauket, New York, United States and 75 other locations

The purpose of this study is to learn about the safety and effects of the vaccine (called COMIRNATY) for the potential prevention of COVID-19...

Active, not recruiting
Myocarditis
Diagnostic Test: Cardiac Imaging

Phase 4

Pfizer
Pfizer

Hartford, Connecticut, United States and 17 other locations

the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...

Active, not recruiting
SARS-CoV-2
Biological: mRNA-1283
Biological: mRNA-1273

Phase 4

Moderna
Moderna

Bridgeport, Connecticut, United States of America and 149 other locations

In this study, the investigators will deploy a software-based clinical decision support tool (eCARTv5) into the electronic health record (EHR) workfl...

Active, not recruiting
COVID-19
Respiratory Failure
Device: eCARTv5 clinical deterioration monitoring
Other: Standard of care control
AgileMD

New Haven, Connecticut, United States and 2 other locations

the chances of contracting coronavirus disease 2019 (COVID-19) or developing a severe form of COVID-19 disease i...

Active, not recruiting
COVID-19 Infection
Plasma Cell Myeloma
Biological: COVID-19 Vaccine
Other: Diagnostic Laboratory Biomarker Analysis

Phase 2

GeoVax

Stony Brook, New York, United States and 5 other locations

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab SC
Drug: Placebo

Phase 3

Eisai
Eisai

New Haven, Connecticut, United States and 249 other locations

treatment in Study M16-067 with no final endoscopy due to the Covid-19 pandemic or due to the geopolitical conflict in Ukraine and ...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: placebo for risankizumab
Drug: risankizumab

Phase 3

AbbVie
AbbVie

New Haven, Connecticut, United States and 435 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems